Selinexor Combination Therapy
Phase Ib/II Study of Selinexor in Combination With Carfilzomib, Subcutaneous Isatuximab Administered Via Investigational Device and Dexamethasone (SCID) for Patients With Relapsed and/or Relapsed Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Phase 2: Selinexor, Carfilzomib, Isatuximab, and Dexamethasone
Accepting patients
Experimental:Phase 1: Selinexor, Carfilzomib, Isatuximab, and Dexamethasone
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.